Ying Li

6.4k citations
187 papers · 4.2k indexed · 1 hit paper · h-index 36
Topics
Immune Cell Function and Interaction (23 papers)RNA modifications and cancer (20 papers)Cancer-related gene regulation (20 papers)

In The Last Decade

Ying Li

173 papers receiving 4.2k citations

Hit Papers

LSD1 Ablation Stimulates Anti-tumor Immunity and Enables ...20182026202020232018100200300400

Peers

Ying Li
Comparison fields: 5 of 135
  • Molecular Biology 2.2k
  • Immunology 1.1k
  • Oncology 882
  • Cancer Research 733
  • Epidemiology 406
Replace Philippe A. Tessier with:
Philippe A. Tessier Canada
Małgorzata Wygrecka Germany
Leland Shapiro United States
Chengjiang Gao China
Frank Autschbach Germany
Karim C. El Kasmi United States
Michael U. Martin Germany
Tohru Akahoshi Japan
Alison M. Condliffe United Kingdom
Frank Bühling Germany
Ying Li relative to Philippe A. Tessier Canada Philippe A. Tessier's profile →
Citations per field
00.5×1.5×2.0×
Philippe A. Tessier · 1×
Citations per year

Countries citing papers authored by Ying Li

Since Specialization
Citations

This map shows the geographic impact of Ying Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Li more than expected).

Fields of papers citing papers by Ying Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Li. The network helps show where Ying Li may publish in the future.

Co-authorship network of co-authors of Ying Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Li. A scholar is included among the top collaborators of Ying Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Li. Ying Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 3
6 1
7 17
8 2
9 2
10 2
11 1
12 12
13 3
14 7
15 232
16 2
17 31
18 30
19 25
20 81

About Ying Li

Ying Li is a scholar working on Immunology, Cancer Research and Molecular Biology, having authored 187 papers that have together received 4.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (23 papers), RNA modifications and cancer (20 papers) and Cancer-related gene regulation (20 papers). The work is most often cited by research in Immunology (1.1k citations), Cancer Research (733 citations) and Molecular Biology (2.2k citations). Ying Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Henry Yang, Aiping Mao, Hong‐Bing Shu, Yong Ran, Shu Li, Pang‐Hung Hsu, Sujun Chen, Housheng Hansen He, Eliezer M. Van Allen and Thao H. Nguyen. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026